Akari Therapeutics (AKTX) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

AKTX is expected to report earnings to rise 1,566.67% to -100 cents per share on September 27

Akari Therapeutics AKTX Stock Earnings Reports

Q2'23

Est.

$-1.00

Q1'23

Est.

$-0.06

Q4'22

Missed

by $0.08

Q3'22

Beat

by $0.02

Q4'21

Est.

$0.00

The last earnings report on June 01 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 6.46K shares outstanding, the current market capitalization sits at 39.69M.

View a ticker or compare two or three

Compare

AKTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For AKTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

22 Boston Wharf Road

Phone

+1 929 274-7510

Employees

Web

https://www.akaritx.com